Full-scale intelligence quotient (FSIQ) on the Wechsler Preschool and Primary Scale of Intelligence, third edition (WPPSI-III)
Secondary outcomes included
Additional measures for executive function | Behavioral checklist
205 children in the awake-regional anesthesia group | 242 in the general anesthesia group
The median duration of general anesthesia: 54 min
The mean FSIQ score was not statistically different between groups
Awake-regional anesthesia group: 99.08
general anesthesia group: 98.97
The results of the intention-to-treat analysis were similar to those of the per-protocol analysis
Previous cohort studies may have been biased by confounding
For example, condition requiring surgery may be associated with adverse neurodevelopmental outcome
Current study only RCT to assess effects on neurodevelopment
There was not statistical differences and strong evidence for equivalence in neurodevelopment at 5 years between those children exposed to approximately 1 hour of regional anesthesia and those children receiving awake regional block
Current FDA warning regarding risks of general anesthesia could have potential harms, including parents and surgeons delaying procedures
The authors state that this study
…being consistent with data from several previous cohort studies, provides strong evidence that just under 1 h of general anaesthesia in infancy does not cause significant neurocognitive or behavioural deficits
Please sign up or log in to your ObGFirst to access this Premium Content
Media - Internet
Computer System Requirements
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
NOT ENOUGH CME HOURS
It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan